![]() |
|
|
Vol. 281, Issue 2, 618-623, 1997
Department of Biological Sciences, Lehman College, Bronx, New York
and Department of Pharmacology, The Panum Institute, University of
Copenhagen, DK-2200 Copenhagen, Denmark
Metformin lowers blood pressure in humans and in experimental animal
models. To determine the mechanism of acute metformin-induced hypotension, we measured changes in mean arterial pressure (MAP) and
heart rate (HR) during metformin alone (0, 10, 50, 100 mg/kg i.v.;
n = 10) and during concomitant alpha
adrenergic (phentolamine, 5 mg/kg; n = 5),
beta adrenergic (propranolol, 3 mg/kg;
n = 6), muscarinic (atropine, 200 µg/kg;
n = 7), ganglionic (hexamethonium, 30 mg/kg;
n = 11), nitric oxide synthase
(NG-methyl-L-arginine acetate salt, 15 mg/kg;
n = 9) and combination ganglionic plus
alpha adrenergic plus beta adrenergic
(n = 6) blockade in spontaneously hypertensive rats
(SHR). Responses to metformin alone were also assessed in normotensive
Wistar-Kyoto rats (n = 6). In SHRs, metformin
elicited depressor responses accompanied by tachycardia (100 mg/kg;
MAP,
26 ± 3 mm Hg;
HR, +49 ± 12 bpm). Depressor
responses in Wistar-Kyoto rats were significantly attenuated (100 mg/kg;
MAP,
9 ± 4 mm Hg; P < .01). Hypotensive actions
of metformin in SHRs were abolished and reversed into pressor responses
by hexamethonium (100 mg/kg;
MAP, +24 ± 6 mm Hg), phentolamine
(100 mg/kg;
MAP, +62 ± 10 mm Hg) and by combination ganglionic
plus adrenergic (100 mg/kg;
MAP, +62 ± 10 mm Hg) blockade. Neither propranolol, atropine nor
NG-methyl-L-arginine acetate salt affected
hypotensive responses to metformin. We conclude that acute intravenous
metformin administration decreases MAP by causing withdrawal of
sympathetic activity. The increase in MAP uncovered by hexamethonium
and phentolamine suggests that the original depressor response to
metformin is buffered by mechanisms unrelated to the autonomic nervous
system.
This article has been cited by other articles:
![]() |
T. Matsumoto, E. Noguchi, K. Ishida, T. Kobayashi, N. Yamada, and K. Kamata Metformin normalizes endothelial function by suppressing vasoconstrictor prostanoids in mesenteric arteries from OLETF rats, a model of type 2 diabetes Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H1165 - H1176. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Smith, M. A. Williams, A. K. Leal, J. H. Mitchell, and M. G. Garry Exercise pressor reflex function is altered in spontaneously hypertensive rats J. Physiol., December 15, 2006; 577(3): 1009 - 1020. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Fruehwald-Schultes, W. Kern, K. M. Oltmanns, S. Sopke, B. Toschek, J. Born, H. L. Fehm, and A. Peters Metformin Does Not Adversely Affect Hormonal and Symptomatic Responses to Recurrent Hypoglycemia J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4187 - 4192. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Peuler Opposing adrenergic actions of intravenous metformin on arterial pressure in female spontaneously hypertensive rats Cardiovasc Res, July 1, 1999; 43(1): 237 - 247. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Muntzel, I. Hamidou, and S. Barrett Metformin Attenuates Salt-Induced Hypertension in Spontaneously Hypertensive Rats Hypertension, May 1, 1999; 33(5): 1135 - 1140. [Abstract] [Full Text] [PDF] |
||||